Proteomics International Proteomics International, Australian Organizations Launching A$4M Research Facility The partners are developing a new lab that will focus on research into protein biomarkers with medical, agricultural, and environmental applications. Proteomics International, Janssen Collaborating to Evaluate PromarkerD Kidney Disease Test The companies will evaluate the performance of Proteomics International's PromarkerD test for predicting decline in kidney function and drug response. Proteomics International Investing in CPR Pharma Services The proteomics firm is swapping 4 million of its shares for a 10 percent interest in CPR with the goal of moving into clinical trials and related research. Proteomics International to Test Kidney Disease Test as CDx for Investigational Treatment Proteomics International's PromarkerD will be tested in clinical studies alongside Dimerix's investigational chronic kidney disease drug DMX-200. Proteomics International Raises $1.4M The company said it will use the funds to commercialize its proteomic PromarkerD kidney disease test and launch an analytical testing service business. Jun 10, 2015 Initial Validation Done, Proteomics International Seeks Partners on Kidney Disease Test Premium Feb 20, 2015 Proteomics International Labs Delays IPO, Lowers Minimum Target Raise Nov 24, 2014 Australia's Proteomics International Laboratories Launches A$6M IPO Mar 4, 2014 Proteomics International, inVentiv Health Collaborate on Biosimilars Development Aug 2, 2013 People in the News: Kevin Conroy, Katherine Napier, David Thompson, and Roopwant Judge Premium Aug 24, 2012 Proteomics International Wins $1M Grant to Develop Protein Test for Diabetic Nephropathy Premium Aug 21, 2012 Proteomics International Snatches $1M Grant to Develop Kidney Disease Biomarkers for CDx Oct 8, 2010 Proteomics International Developing Protein Biomarker-Based Diagnostic for Diabetic Nephropathy Premium May 24, 2010 Proteomics International Hires 1st Base as Agent in Parts of Asia Aug 24, 2009 Proteomics International Gains ISO Certification Aug 13, 2009 Busselton Health Study Turns to Proteomics to Discover 'Diabesity' Biomarkers Premium Apr 16, 2009 Proteomics International Using Arthropod Venom for New Peptide Drug-Discovery Premium Breaking News New Approach Identifies Candidate Causal Variants for Neuropsychiatric, Neurodevelopmental Conditions People in the News: Baylor's Thomas Caskey Dies; New Appointments at UK Biobank, CS Genetics, More In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable The Scan Omicron's Sewage Path The New York Times writes that testing sewage is helping public health officials track Omicron. IBM Sells Part of Watson Health The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm. Identifying the Right Whales The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought. Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.